Skip to main content
Nykode Therapeutics AS (VACBF)
OTCMKTS · Delayed Price · Currency is USD
0.2046
-0.0245 (-10.69%)
At close: Jun 3, 2025

Nykode Therapeutics AS Revenue

Nykode Therapeutics AS had revenue of $137.00K in the quarter ending March 31, 2025, a decrease of -86.52%. This brings the company's revenue in the last twelve months to $8.28M, down -24.95% year-over-year. In the year 2024, Nykode Therapeutics AS had annual revenue of $9.16M, down -31.26%.

Revenue (ttm)
8.28M
Revenue Growth
-24.95%
P/S Ratio
6.91
Revenue / Employee
110.39K
Employees
136
Market Cap
57.20M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20249.16M-4.17M-31.26%
Dec 31, 202313.32M4.29M47.56%
Dec 31, 20229.03M-26.74M-74.76%
Dec 31, 202135.77M-179.93M-83.42%
Dec 31, 2020215.70M214.28M15,175.85%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo, Inc. 1.73B
Elite Pharmaceuticals 70.00M
Veradigm 588.02M
Tian'an Technology Group 1.78M
American Oncology Network 1.76B
Glass House Brands 215.62M
Northwest Biotherapeutics 1.47M
Silence Therapeutics 27.70M
Revenue Rankings

Nykode Therapeutics AS News

More News